Dr. Hirawat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Cross Gates Rd
Madison, NJ 07940Phone+1 201-787-5392- Is this information wrong?
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 1999 - 2002
- Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1996 - 1999
- Sawai Man Singh Medical CollegeClass of 1994
Certifications & Licensure
- NJ State Medical License 2004 - 2025
Publications & Presentations
PubMed
- 502 citationsRibociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trialDebu Tripathy, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Nadia Harbeck, Sara A. Hurvitz, Louis W.C. Chow, Joohyuk Sohn, Keun Seok Lee, Saúl Campos-Góme...> ;The Lancet. Oncology. 2018 Jul 1
- 142 citationsBuparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-bli...Denis Soulières, Sandrine Faivre, Ricard Mesia, Éva Remenár, Shau-Hsuan Li, Andrey Karpenko, Arunee Dechaphunkul, Sebastian Ochsenreither, Laura Anna Kiss, Jin-Ching L...> ;The Lancet. Oncology. 2017 Mar 1
- 195 citationsSafety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single‐ and Multiple‐Dose Administration to Healthy M...Samit Hirawat, Ellen Welch, Gary Elfring, Valerie Northcutt, Sergey Paushkin, Seongwoo Hwang, Eileen M. Leonard, Neil Gregory Almstead, William D. Ju, Stuart W. Peltz,...> ;Journal of Clinical Pharmacology. 2007 Apr 1
- Join now to see all
Press Mentions
- BMS’s LPA1 Antagonist to Enter Phase III IPF TrialMay 23rd, 2023
- Bristol Myers Squibb to Highlight Diversified Approaches and Commitment to Improving Outcomes for Patients with Cancer and Serious Blood Disorders at ASCO, EHA and ICML 2023May 11th, 2023
- Bristol Myers Squibb Sotyktu Gets European Commission Nod for Adults with Plaque PsoriasisMarch 29th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: